PLCG2 and Autoimmunity: Indeed, many of the somatic PLCG2 variants observed in the context of BTKi therapy overlap with those occurring in autoimmune PLCG2-associated immune dysregulation (APLAID), an inherited syndrome caused by germline gain-of-function PLCG2 variants [25].